Correlations between gait speed, 6-minute walk distance, physical activity, and self-efficacy in patients with severe chronic lung disease

Respiratory Care

Volumn 58, Issue 12, 2013, Pages 2113-2119

  De Pew, Zachary S ^a   Karpman, Craig ^a   Novotny, Paul J ^a   Benzo, Roberto P ^a  

^a MAYO CLINIC   (United States)

Author keywords

6 min walk test; COPD; Exercise capacity; Gait speed; Interstitial lung disease

Indexed keywords

CARBON MONOXIDE;

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; DYSPNEA; EXERCISE; FEMALE; FOUR METER GAIT SPEED; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; GAIT; HUMAN; INTERSTITIAL PNEUMONIA; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PULMONARY HYPERTENSION; QUALITY OF LIFE; SCORING SYSTEM; SELF CONCEPT; SIX MINUTE WALK DISTANCE TEST; SOCIAL BEHAVIOR; TASK PERFORMANCE; VELOCITY; VITAL CAPACITY;

6-MIN WALK TEST; COPD; EXERCISE CAPACITY; GAIT SPEED; INTERSTITIAL LUNG DISEASE;

ACTIVITIES OF DAILY LIVING; AGED; CHRONIC DISEASE; DYSPNEA; EXERCISE TEST; FEMALE; GAIT; HUMANS; LOGISTIC MODELS; LUNG DISEASES; MALE; MEANINGFUL USE; MIDDLE AGED; MOTOR ACTIVITY; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; SELF EFFICACY; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; WALKING;

EID: 84888119185     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02471     Document Type: Article

References (41)

1. Abellan Van Kan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) task force. J Nutr Health Aging 2009;13(10):881-889.
2. Buchner D, Larson E, Wagner E, Koepsell T, De Lateur B. Evidence for a non-linear relationship between leg strength and gait speed. Age Ageing 1996;25(5):386-391.
3. Dumurgier J, Elbaz A, Ducimetiere P, Tavernier B, Alperovitch A, Tzourio C. Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study. BMJ 2009;339: b4460.
4. Guralnik J, Ferrucci L, Simonsick E, Salive M, Wallace R. Lowerextremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995;332(9):556-561.
5. Perera S, Mody S, Woodman R, Studenski S. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc 2006;54(5):743-749.
6. Steffen T, Hacker T, Mollinger L. Age-and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds. Phys Ther 2002;82(2):128-137.
7. Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, et al. Gait speed and survival in older adults. JAMA 2011;305(1): 50-58.
8. Studenski S, Perera S, Wallace D, Chandler J, Duncan P, Rooney E, et al. Physical performance measures in the clinical setting. J Am Geriatr Soc 2003;51(3):314-322.
9. Butcher SJ, Meshke JM, Sheppard MS. Reductions in functional balance, coordination, and mobility measures among patients with stable chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2004;24(4):274-280.
10. Ilgin D, Ozalevli S, Kilinc O, Sevinc C, Cimrin A, Ucan E. Gait speed as a functional capacity indicator in patients with chronic obstructive pulmonary disease. Ann Thoracic Med 2011;6(3):141-146.
11. Kon SS, Patel MS, Canavan JL, Clark AL, Jones SE, Nolan CM, et al. Reliability and validity of the four metre gait speed in COPD. Eur Respir J 2013;42(2):333-340.
12. Benzo R. Factors to inform clinicians about end of life in severe COPD. J Pain Symptom Manage 2013;46(4):491-499.e4.
13. Kongsgaard M, Backer V, Jorgensen K, Kjaer M, Beyer N. Heavy resistance training increases muscle size, strength and physical function in elderly male COPD-patients: a pilot study. Respir Med 2004; 98(10):1000-1007.
14. Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, et al. Six minute walk test in COPD: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med 2013;187(4):382-386.
15. Fritz S, Lusardi M. White paper: "walking speed: the sixth vital sign". J Geriatr Phys Ther 2009;32(2):2-5.
16. Studenski S. Bradypedia: is gait speed ready for clinical use? J Nutr Health Aging 2009;13(10):878-880.
17. Blanchard CM, Fortier M, Sweet S, O'Sullivan T, Hogg W, Reid RD, et al. Explaining physical activity levels from a self-efficacy perspective: the physical activity counseling trial. Ann Behav Med 2007;34(3):323-328.
18. Kaplan RM, Atkins CJ, Reinsch S. Specific efficacy expectations mediate exercise compliance in patients with COPD. Health Psychol 1984;3(3):223-242.
19. Kim C, McEwen LN, Kieffer EC, Herman WH, Piette JD. Selfefficacy, social support, and associations with physical activity and body mass index among women with histories of gestational diabetes mellitus. Diabetes Educ 2008;34(4):719-728.
20. Rodgers WM, Sullivan MJL. Task, coping, and scheduling selfefficacy in relation to frequency of physical activity. J Appl Soc Psychol 2001;31(4):741-753.
21. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54(7):581-586.
22. Bretscher M, Rummans T, Sloan J, Kaur J, Bartlett A, Borkenhagen L, et al. Quality of life in hospice patients: a pilot study. Psychosomatics 1999;40(4):309-313.
23. Brown PD, Maurer MJ, Rummans TA, Pollock BE, Ballman KV, Sloan JA, et al. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurg 2005;57(3): 495-503.
24. Locke DE, Decker PA, Sloan JA, Brown PD, Malec JF, Clark MM, et al. Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. J Pain Symptom Manage 2007;34(6):628-638.
25. Spitzer WO, Dobson AJ, Hall J. Measuring the quality of life of cancer patients. A concise QL-index for use by physicians. J Chron Dis 1981;34(12):585-597.
26. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005; 26(2):319-338.
27. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111-117.
28. Hill K, Dolmage TE, Woon L, Goldstein R, Brooks D. Measurement properties of the SenseWear armband in adults with chronic obstructive pulmonary disease. Thorax 2010;65(6):486-491.
29. Patel SA, Benzo RP, Slivka WA, Sciurba FC. Activity monitoring and energy expenditure in COPD patients: a validation study. J COPD 2007;4(2):107-112.
30. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 2008;177(7):743-751.
31. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998;158(5 Pt 1): 1384-1387.
32. Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. Eur Respir J 2009;33(2):262-272. Erratum in: Eur Respir J 2010;36(2):462.
33. Caminati A, Bianchi A, Cassandro R, Rosa Mirenda M, Harari S. Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis. Respir Med 2009;103(1):117-123.
34. Chang J, Curtis J, Patrick D, Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest 1999; 116(5):1175-1182.
35. Cote C, Pinto-Plata V, Kasprzyk K, Dordelly L, Celli B. The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest 2007;132(6):1778-1785.
36. Kawut S, O'Shea M, Bartels M, Wilt J, Sonett J, Arcasoy S. Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir Med 2005;99(11): 1431-1439.
37. Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, Fujita M, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000;161(2 Pt 1):487-492.
38. Oga T, Nishimura K, Tsukino M, Hajiro T, Ikeda A, Mishima M. Relationship between different indices of exercise capacity and clinical measures in patients with chronic obstructive pulmonary disease. Heart Lung 2002;31(5):374-381.
39. Taichman DB, Shin J, Hud L, Archer-Chicko C, Kaplan S, Sager JS, et al. Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res 2005;6:92. DOI: 10.1186/1465-9921-6-92.
40. Waschki B, Kirsten A, Holz O, Muller KC, Meyer T, Watz H, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011;140(2): 331-342.
41. Leung A, Chan K, Sykes K. Reliability, validity, and responsiveness of a 2-min walk test to assess exercise capacity of COPD patients. Chest 2006;130(1):119-125.